Zibin Lu

810 total citations
35 papers, 603 citations indexed

About

Zibin Lu is a scholar working on Molecular Biology, Immunology and Pharmacology. According to data from OpenAlex, Zibin Lu has authored 35 papers receiving a total of 603 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 14 papers in Immunology and 6 papers in Pharmacology. Recurrent topics in Zibin Lu's work include Immune Response and Inflammation (11 papers), Pharmacological Effects of Natural Compounds (6 papers) and Mosquito-borne diseases and control (5 papers). Zibin Lu is often cited by papers focused on Immune Response and Inflammation (11 papers), Pharmacological Effects of Natural Compounds (6 papers) and Mosquito-borne diseases and control (5 papers). Zibin Lu collaborates with scholars based in China, Hong Kong and United States. Zibin Lu's co-authors include Linzhong Yu, Junshan Liu, Huihui Cao, Hongling Zhou, Huayi Yang, Chuying Huo, Peitao Xie, Yuyao Chen, Chun‐Lin Fan and Lijuan Deng and has published in prestigious journals such as Biochemical Pharmacology, Journal of Ethnopharmacology and Advanced Science.

In The Last Decade

Zibin Lu

33 papers receiving 596 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Zibin Lu China 15 325 117 87 87 85 35 603
Joo‐Hui Han South Korea 18 502 1.5× 107 0.9× 141 1.6× 57 0.7× 72 0.8× 46 928
Tianhui Gao China 15 366 1.1× 72 0.6× 59 0.7× 124 1.4× 102 1.2× 41 740
Kuen‐Daw Tsai Taiwan 13 306 0.9× 82 0.7× 47 0.5× 68 0.8× 76 0.9× 20 678
Yonger Chen China 14 287 0.9× 70 0.6× 74 0.9× 48 0.6× 124 1.5× 20 609
Yiyi Jin China 16 353 1.1× 108 0.9× 54 0.6× 44 0.5× 66 0.8× 31 747
Bin‐Feng Cheng China 17 409 1.3× 73 0.6× 47 0.5× 103 1.2× 180 2.1× 47 792
Shanting Liao China 12 326 1.0× 187 1.6× 79 0.9× 65 0.7× 60 0.7× 18 586
Liping Bao China 7 285 0.9× 130 1.1× 63 0.7× 85 1.0× 56 0.7× 11 624
Dujuan Xu China 16 354 1.1× 56 0.5× 63 0.7× 118 1.4× 128 1.5× 33 661

Countries citing papers authored by Zibin Lu

Since Specialization
Citations

This map shows the geographic impact of Zibin Lu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zibin Lu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zibin Lu more than expected).

Fields of papers citing papers by Zibin Lu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zibin Lu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zibin Lu. The network helps show where Zibin Lu may publish in the future.

Co-authorship network of co-authors of Zibin Lu

This figure shows the co-authorship network connecting the top 25 collaborators of Zibin Lu. A scholar is included among the top collaborators of Zibin Lu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zibin Lu. Zibin Lu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
He, Xuemei, Bing Chen, Peng Guo, et al.. (2025). Daidzin protects against dengue virus infection by targeting viral envelope protein. Industrial Crops and Products. 226. 120658–120658. 1 indexed citations
2.
3.
Yang, Liling, Junshan Liu, Guangli Yang, et al.. (2025). PEBL, a component-based Chinese medicine, reduces virus-induced acute lung injury by targeting FXR to decrease ACE2 levels. Journal of Advanced Research. 80. 1099–1119. 1 indexed citations
4.
Yang, Jiabin, Xi Chen, Xuemei He, et al.. (2024). Tanreqing injection demonstrates anti-dengue activity through the regulation of the NF-κB-ICAM-1/VCAM-1 axis. Phytomedicine. 130. 155764–155764. 1 indexed citations
5.
He, Xuemei, Zibin Lu, Huihui Cao, et al.. (2024). Tanreqing injection inhibits dengue virus encephalitis by suppressing the activation of NLRP3 inflammasome. Chinese Medicine. 19(1). 24–24. 2 indexed citations
6.
Lu, Zibin, Bing Chen, Xuemei He, et al.. (2024). Liang–Ge–San protects against viral infection-induced acute lung injury through inhibiting α7nAChR-mediated mitophagy. Phytomedicine. 135. 156231–156231. 4 indexed citations
7.
Yan, Lijun, Xiangjun Zhou, Guangli Yang, et al.. (2023). Liang-Ge-San: a classic traditional Chinese medicine formula, attenuates acute inflammation via targeting GSK3β. Frontiers in Pharmacology. 14. 1181319–1181319. 1 indexed citations
8.
Chen, Xi, Huihui Cao, Chunyang Tian, et al.. (2023). N-butanol Extract of Glycyrrhizae Radix et Rhizoma Inhibits Dengue Virus through Targeting Envelope Protein. Pharmaceuticals. 16(2). 263–263. 3 indexed citations
9.
Chen, Xi, Jiabin Yang, Huihui Cao, et al.. (2023). Liang-Ge-San inhibits dengue virus serotype 2 infection by reducing caveolin1-induced cytoplasmic heat shock protein 70 translocation into the plasma membrane. Phytomedicine. 119. 154977–154977. 5 indexed citations
10.
Tian, Chunyang, Xuemei He, Lijun Yan, et al.. (2023). Identification of an effective fraction from Ampelopsis Radix with anti-dengue virus activities in vitro and in vivo. Journal of Ethnopharmacology. 309. 116339–116339. 5 indexed citations
11.
Zhou, Chunhong, Linzhong Yu, Huihui Cao, et al.. (2023). Ethyl Lithospermate Reduces Lipopolysaccharide-Induced Inflammation through Inhibiting NF-κB and STAT3 Pathways in RAW 264.7 Cells and Zebrafish. Chinese Journal of Integrative Medicine. 29(12). 1111–1120. 3 indexed citations
12.
Tian, Chunyang, Chun‐Lin Fan, Junjie Xiao, et al.. (2020). Sheng-Mai Yin exerts anti-inflammatory effects on RAW 264.7 cells and zebrafish. Journal of Ethnopharmacology. 267. 113497–113497. 29 indexed citations
13.
Fan, Chun‐Lin, Chunyang Tian, Zibin Lu, et al.. (2020). Holistic quality evaluation of Qingwen Baidu Decoction and its anti-inflammatory effects. Journal of Ethnopharmacology. 263. 113145–113145. 13 indexed citations
14.
Lu, Zibin, Huihui Cao, Chunyang Tian, et al.. (2020). Forsythoside A inhibits adhesion and migration of monocytes to type II alveolar epithelial cells in lipopolysaccharide-induced acute lung injury through upregulating miR-124. Toxicology and Applied Pharmacology. 407. 115252–115252. 14 indexed citations
15.
You, Yanting, Xinghong Zhou, Liqian Chen, et al.. (2020). Silibinin Induces G2/M Cell Cycle Arrest by Activating Drp1-Dependent Mitochondrial Fission in Cervical Cancer. Frontiers in Pharmacology. 11. 271–271. 28 indexed citations
16.
Li, Xiaowei, Zibin Lu, Fenghua Zhou, et al.. (2020). Indoxyl sulfate promotes the atherosclerosis through up-regulating the miR-34a expression in endothelial cells and vascular smooth muscle cells in vitro. Vascular Pharmacology. 131. 106763–106763. 15 indexed citations
17.
Lu, Zibin, Peitao Xie, Dongmei Zhang, et al.. (2018). 3-Dehydroandrographolide protects against lipopolysaccharide-induced inflammation through the cholinergic anti-inflammatory pathway. Biochemical Pharmacology. 158. 305–317. 39 indexed citations
18.
Xie, Shuwen, Yanni Wang, Hui Luo, et al.. (2017). [Inhibitory effect of giganteaside D on hepatocellular carcinoma Hep 3b cells and the underlying mechanisms].. PubMed. 37(9). 1211–1216. 1 indexed citations
19.
Gong, Wangqiu, Lu Lu, Jing Chen, et al.. (2016). Irbesartan ameliorates hyperlipidemia and liver steatosis in type 2 diabetic db/db mice via stimulating PPAR-γ, AMPK/Akt/mTOR signaling and autophagy. International Immunopharmacology. 42. 176–184. 60 indexed citations
20.
Liu, Junshan, Yanni Wang, Yuwen Qiu, et al.. (2016). Giganteaside D induces ROS-mediated apoptosis in human hepatocellular carcinoma cells through the MAPK pathway. Cellular Oncology. 39(4). 333–342. 28 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Joo‐Hui Han Breakdown of academic impact, for papers by Tianhui Gao Breakdown of academic impact, for papers by Kuen‐Daw Tsai Breakdown of academic impact, for papers by Yonger Chen Breakdown of academic impact, for papers by Yiyi Jin Breakdown of academic impact, for papers by Bin‐Feng Cheng Breakdown of academic impact, for papers by Shanting Liao Breakdown of academic impact, for papers by Liping Bao Breakdown of academic impact, for papers by Dujuan Xu
Rankless by CCL
2026